Harmony Biosciences Holdings (HRMY) Other Operating Expenses (2019 - 2026)

Harmony Biosciences Holdings' Other Operating Expenses history runs 8 years deep, the most recent figure standing at $31.7 million for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 3.2% year-over-year to $31.7 million; the TTM figure through Mar 2026 stood at $155.7 million (up 36.07% YoY), while the FY2025 annual figure was $119.5 million, up 7.75% from the prior year.
• Other Operating Expenses came in at $31.7 million for Q1 2026 at Harmony Biosciences Holdings, up from $29.2 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $65.2 million in Q2 2025 to a low of $17.6 million in Q1 2022.
• A 5-year average of $27.9 million and a median of $27.2 million in 2024 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses rose 2.66% in 2024 and surged 128.83% in 2025, its largest moves.
• Harmony Biosciences Holdings' Other Operating Expenses stood at $21.1 million in 2022, then increased by 27.57% to $26.9 million in 2023, then increased by 2.66% to $27.6 million in 2024, then advanced by 5.72% to $29.2 million in 2025, then increased by 8.62% to $31.7 million in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $31.7 million, $29.2 million, and $29.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison